Appointment of Chief Commercial Officer
Nasdaq notice BMGL 2025
Nasdaq Issues Non-Compliance Notice to Basel Medical Group
Appointment of Chief Commercial Officer
Nasdaq notice BMGL 2025
Nasdaq Issues Non-Compliance Notice to Basel Medical Group

Basel Medical Group Full-Year 2025 Earnings Report

Singapore – Nov 18, 2025 – Basel Medical Group Ltd

Basel Medical Group Ltd reported its earnings results for the full year ended June 30, 2025. The company's sales grew to SGD 11.32 million, an increase from SGD 10.05 million reported a year ago. However, the period saw a significant reversal in profitability, with the company recording a net loss of SGD 12.09 million. This compares sharply to the net income of SGD 2.07 million the company reported in the previous year.

 

For full detail of the report, click the link below:

Annual Report 2025